Status:
ACTIVE_NOT_RECRUITING
The Use of MicroRNAs Dysregulation as Potential Biomarkers for Effective Diagnosis of Endometriosis
Lead Sponsor:
Asian Institute of Gastroenterology, India
Conditions:
Endometriosis
Eligibility:
All Genders
18-45 years
Phase:
NA
Brief Summary
OBJECTIVES : 1. To investigate the expression pattern of miRNAs operational in inflammation, angiogenesis, hypoxia, apoptosis and cell proliferation in eutopic and ectopic endometrium of patients wit...
Detailed Description
METHODOLOGY : 1 Investigator will take Both blood and tissue samples used to study them. 2. Investigator will take approximately 3 ml of blood which will be used from the blood sample collected for r...
Eligibility Criteria
Inclusion
- Patients having more severe forms of endometriosis (Stage III and IV)
- The probands were chosen randomly from the pool of available endometriosis patients and healthy controls of Indian origin.
Exclusion
- Diagnosis of non-endometriotic ovarian cysts, adenomyosis, ovarian cancer, fibroids, and stage I and II endometriosis.
- Exclusion criteria defined for the control group were personal history of chronic pelvic pain, secondary dysmenorrhea, abnormal uterine bleeding and family history of endometriosis.
Key Trial Info
Start Date :
November 15 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 15 2026
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06168097
Start Date
November 15 2023
End Date
December 15 2026
Last Update
December 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shraddha Ramchandani
Hyderabad, Telanagana, India, 500082